MONDINI, LUCREZIA
 Distribuzione geografica
Continente #
AS - Asia 74
EU - Europa 52
NA - Nord America 44
Totale 170
Nazione #
US - Stati Uniti d'America 44
HK - Hong Kong 40
IT - Italia 24
SG - Singapore 15
CN - Cina 14
FI - Finlandia 14
KR - Corea 5
SE - Svezia 5
CH - Svizzera 4
DE - Germania 2
IE - Irlanda 1
NL - Olanda 1
UA - Ucraina 1
Totale 170
Città #
Hong Kong 39
Ashburn 10
Beijing 8
Chandler 7
Helsinki 7
Lappeenranta 7
Trieste 7
Seoul 5
Bern 4
Boardman 4
Mantova 3
Singapore 3
Bologna 2
Los Angeles 2
Princeton 2
Brescia 1
Cesena 1
Dublin 1
Hamburg 1
Padova 1
Pasian di Prato 1
Redmond 1
San Severo 1
Seattle 1
Shanghai 1
Trento 1
Valsamoggia 1
Washington 1
Totale 123
Nome #
Severe COVID‐19 ARDS Treated by Bronchoalveolar Lavage with Diluted Exogenous Pulmonary Surfactant as Salvage Therapy: In Pursuit of the Holy Grail? 45
Host-Based Treatments for Severe COVID-19 30
Microvascular Alteration in COVID-19 Documented by Nailfold Capillaroscopy 21
Pulmonary Sarcoidosis and Immune Dysregulation: A Pilot Study on Possible Correlation 20
Theory and Practice of Glucocorticoids in COVID-19: Getting to the Heart of the Matter-A Critical Review and Viewpoints 19
Biomarkers in Systemic Sclerosis: An Overview 19
Functional Progression after Dose Suspension or Discontinuation of Nintedanib in Idiopathic Pulmonary Fibrosis: A Real-Life Multicentre Study 17
Nailfold Capillaroscopy Analysis Can Add a New Perspective to Biomarker Research in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis 12
Vascular Endothelial Damage in COPD: Where Are We Now, Where Will We Go? 9
Pirfenidone and Nintedanib in Pulmonary Fibrosis: Lights and Shadows 8
Totale 200
Categoria #
all - tutte 1.228
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.228


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224 0 0 0 0 0 0 0 0 0 0 0 4
2022/202334 3 3 2 2 2 5 0 3 5 0 4 5
2023/2024152 6 7 6 15 13 10 32 31 6 3 19 4
2024/202510 10 0 0 0 0 0 0 0 0 0 0 0
Totale 200